Exagen Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Exagen Inc. on April 25, 2022. The filing discloses the adoption of a new executive compensation arrangement rather than reporting financial results for a specific fiscal period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the terms of a new severance plan.
Material Changes
On April 25, 2022, the Compensation Committee adopted the Exagen Inc. Amended and Restated Executive Change in Control and Severance Plan. This plan supersedes all prior severance plans and policies for designated executives. The key changes include:
- Expanded Coverage: The plan now includes non-change-in-control severance benefits in addition to change-in-control benefits.
- Designated Participants: Fortunato Ron Rocca (CEO), Kamal Adawi (CFO), Mark Hazeltine (COO), and Debra Zack (CMO) are designated participants.
- Non-Change-in-Control Termination: Executives terminated without "cause" outside of a change-in-control window receive 50% of annual base salary (75% for the CEO), a pro-rated performance bonus, and up to 6 months of COBRA subsidies (9 months for the CEO).
- Change-in-Control Termination: Executives terminated without "cause" or for "good reason" within 12 months of a change in control receive 100% of annual base salary (125% for the CEO), a pro-rated performance bonus, up to 12 months of COBRA subsidies (15 months for the CEO), and full accelerated vesting of time-based equity awards.
Guidance, Outlook, and Risks
The filing does not contain financial guidance or management commentary on business outlook. The primary contingency noted is that severance payments are subject to the executive signing a general release of claims and complying with restrictive covenants. Additionally, payments are subject to a "golden parachute" reduction if they would trigger an excise tax under Section 4999 of the Internal Revenue Code, adjusted to maximize the executive's net after-tax result.
Investor Verification Checklist
- Review Exhibit 10.1 for the full legal text of the Amended and Restated Severance Plan.
- Verify the current annual base salaries of the designated executives to calculate potential severance liabilities.
- Assess the company's current cash position to determine the ability to fund lump-sum severance payments if triggered.
- Monitor for any future filings regarding executive departures or change-in-control events.